BOUDREAUX GAIL 1287920 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Boudreaux Gail | PRESIDENT AND CEO | acq | 42932.0 | 26.71 | 1.85 | 0.0 | Direct | Common Stock | ELEVANCE HEALTH, INC. | code A | 160709.0 | 232.67 (ELV) |
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Boudreaux Gail | PRESIDENT AND CEO | dsp | 19256.0 | 14.05 | 0.83 | 499.11 | Direct | Common Stock | ELEVANCE HEALTH, INC. | code F | 117777.0 | 232.67 (ELV) |
2024-03-05 | 2024-03-01 | 4 | Boudreaux Gail | PRESIDENT AND CEO | holding | 60.0 | 0 | 0.0 | 0.0 | Shares Held In Spouse's Revocable Trust | Common Stock | ELEVANCE HEALTH, INC. | NA | 232.67 (ELV) | ||
2024-03-15 | 2024-03-13 | 2024-03-13 | 4 | Boudreaux Gail | DIRECTOR | acq | 1873.0 | 31.65 | 0.04 | 0.0 | Direct | Common Stock | TARGET CORP | code A | 5918.0 | 461.66 (TGT) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Boudreaux Gail | PRESIDENT AND CEO | acq | 32480.0 | 100.0 | 1.4 | 499.11 | Direct | Employee Stock Option (Right To Buy) | ELEVANCE HEALTH, INC. | code A | 32480.0 | 232.67 (ELV) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)